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1 . Introduction 
When carcinogenic polycyclic hydrocarbons like 
benzo(a)pyrene (I) are metabolized, derivatives are 
formed that react with cellular macromolecules [ 1,2] . 
The positive identification of the reactive metabolites 
concerned has been hindered by the very low levels 
of reaction with nucleic acids that occur in tissues 
treated with these chemical carcinogens, although 
some progress has been made using radioactively- 
labelled hydrocarbons [3]. A fresh approach to this 
problem has been made possible by the construction 
of a highly sensitive spectrophotofluorometer that 
incorporates a photon-counting device [4]. The 
instrument allows the fluorescence characteristics of 
polycyclic hydrocarbon-modified nucleic acids that 
have been isolated from treated tissues to be investi- 
gated directly without prior degradative or chromato- 
graphic procedures [5] . We report here the results of 
the first studies on benzo(u)pyrene undertaken with 
this spectrophotofluorometer in which the fluorescence 
spectral characteristics of DNA from benzo(a)pyrene- 
treated mouse skin have been compared with those 




2. Materials and methods 
2.1. Materials 
Benzo(u)pyrene, purified by recrystallization from 
xylene, and DNA (salmon sperm, type III), depro- 
teinized by a detergent salt procedure [6], were 
purchased from Sigma Chemical Co., St, Louis, MO., 
U.S.A. m-Chloroperoxybenzoic acid was obtained 
from BDH Chemicals Ltd., Poole, Dorset, U. K. 
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene and 9,10- 
dihydro-9,10-dihydroxybenzo(u)pyrene were obtained 
from the hydrocarbon by metabolism [7] ; the cor- 
responding diol-epoxides, 7,8-dihydro-7,%dihydroxy- 
benz(u)pyrene 9,10-oxide and 9,10-dihydro-9,10- 
dihydroxybenzo(a)pyrene 7,8-oxide were prepared 
from the diols by oxidation with m-chloroperoxy- 
benzoic acid in benzene. Benzo(a)pyrene 4,5oxide 
was also synthesized [SJ . 
2.2. Reactions with DNA 
DNA (10 mg) dissolved in Tris-HC 1 buffer (0.1 M, 
pH 7.0, 10 ml) was mixed with acetone (5 ml) or 
with a solution of a benzo(a)pyrene epoxide (200 .,ug) 
in acetone (5 ml) and incubated for 18 h at 37°C. 
After incubation and extraction with ether (2 x 1 vol.), 
NaCl (s 1 M) was added and DNA reprecipitated with 
ethanol and purified by passage through GlO Sepha- 
dex and extraction with chloroform: isoamyl alcohol 
t24 : 1, 1 vol.). After concentration by lyophiliza- 
tion, NaCl was added (s 1 M), the DNA was 
reprecipitated with ethanol (2 vol.) and then washed 
extensively with ethanol. DNA was finally redis- 
solved in Tris-NaCl buffer (0.01 M, pH 7.4) and 
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dialysed (48 h) against his buffer (2000 vol.) before 
fluorescence spectra were recorded. DNA was also iso- 
lated from mouse skin following treatment with 
benzo(u)pyrene. The backs of groups of 15 male 
C57Bl mice were shaved and treated with acetone 
(0.15 ml) or with benzo(a)pyrene (250 pg) in 
acetone (0.15 ml). After 24 h the mice were killed, 
the treated skin removed, frozen in liquid Nz and 
the dermal surface scraped with a scalpel. The frozen 
epidermal layers were cut into fragments and homo- 
genized in liquid Nz using an Ultra-Turrax (Janke and 
Kunkel, K. G., Staufen, Germany). DNA, isolated as 
described [9], was further purified as described above. 
2.3. Fluorescence spectra 
These were obtained using the photon-counting 
spectrophotofluorometer [4]. The points plotted by 
the instrument (fig. 1) show the fluorescence mitted 
by the sample at that wavelength in 10 s using solu- 
tions of DNA treated with 7,8-dihydro-7,8-dihydroxy- 
benzo(a)pyrene 9,1 O-oxide. Excitation wavelength 
302.5 nm with A&, = 4.2 nm. Band width of the 
analysis path A\ = 6.4 nm; concentration of DNA, 
700 pClg/ml. All the spectra shown in fig.2 are differ- 
ence spectra where the fluorescence contribution of 
the relevant control DNA has been subtracted; these 
were obtained with the instrument settings given 
above. 
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Fig.1. Fluorescence spectra shown by 1, DNA reacted with 
7,8-dihydro-7,8dihydroxybenzo(a)pyrene 9,10-oxide and 2, 
DNA, both recorded using the photon-counting spectrophoto- 
fluorometer. Measurements were made as described in the text. 
3. Results and discussion 
Since evidence that implicated 7,8-dihydro-7,8- 
dihydroxybenzo(a)pyrene 9,10-oxide in the metabolic 
activation of benzo(a)pyrene existed [7], the fluor- 
escence spectrum of DNA that had been reacted with 
this diol-epoxide was compared with that of benzo(u) 
pyrene-treated mouse skin DNA. Fig2(c) shows that 
the main fluorescence characteristics of DNA isolated 
from the hydrocarbon-treated mouse skin very closely 
resemble those of salmon sperm DNA treated with 
the 7,8-diol 9,10-epoxide. Apart from the characte- 
ristics contributed by the diol-epoxide (fig.2(a) I), 
spectral contributions from two other components 
(fig.2(a), II and III), which have not been identified, 
also appear to be present in DNA isolated from 
benzo(a)pyrene treated mouse skin. Figure2(b) shows 
the fluorescence spectra of salmon sperm DNA 
reacted with benzo(a)pyrene 7,8-diol 9,lO-epoxide or 
with the isomeric 9,10-diol 7,8-epoxide; these cannot 
be distinguished from one another and both show 
maxima at 382.5 and 402 nm. Other evidence indi- 
cates, however, that the 9,10-diol 7,&epoxide is not 
involved in the metabolic activation of benzo(a)pyrene 
in vivo [7] . Earlier work had shown that simple K- 
region epoxides derived from polycyclic hydrocarbons 
possessed properties relevant to carcinogenesis [lo] and 
that benzo(u)pyrene 4,5-oxide was formed as a micro- 
somal metabolite [1 l] . The DNA products that are 
formed, however, when benzo(a)pyrene is metabo- 
lized in vivo do not seem to result from reaction with 
this K-region epoxide [7,12]. The fluorescence spec- 
tral studies carried out using DNA treated with 
benzo(a)pyrene 4,5-oxide confirm this; the fluor- 
escence maxima for the K-region epoxide-reacted 
DNA, at 371.5 and 390 nm (tig.2(c)), are clearly 
different from those of benzo(a)pyrene-treated mouse 
skin DNA and of diol-epoxide reacted DNA. Fig.2(c) 
also gives, for comparative purposes, the fluores- 
cence spectrum of benzo(a)pyrene itself, which is 
quite distinct from the others obtained. 
The use of the photon-counting spectrophoto- 
fluorometer has permitted the fluorescence mitted 
by benzo(a)pyrene derivatives that have become 
bound to DNA in vivo to be examined for the first 
time. The spectra obtained show that the main 
benzo(a)pyrene derivative bound to the DNA of 
mouse skin, a tissue in which benzo(a)pyrene is car- 
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cinogenic, retains an intact pyrene nucleus (fig.2). 
This indicates that metabolism of the 7,8,9,10-ring 
precedes reaction with DNA and is consistent with 
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Fig.2. Fluorescence spectra shown by (a) , DNA 
isolated from mouse skin following treatment with benzo(a> 
pyrene. .-.-.-.--.-, DNA treated with 7,8dihydro-7,8-dihy- 
droxybenzo(u)pyrene 9,10-oxide. (b) ----, DNA reacted 
with 7,8-dihydro_7,&dihydroxybenzo(a)pyrene 9,10-oxide. 
-..-..-..-..-.., DNA reacted with 9,10-dihydro-9,10-dihy- 
droxybenzo(a)pyrene 7,8-oxide. (c) benzo(a)- 
pyrene, measured as a solution in methanol. -.L.-.-.-., DNA 
reacted with benzo(a)pyrene 4,5-oxide. Measurements were 
made as described in the text. 
the hypothesis that a dial-epoxide formed on this 
ring is involved [7]. The spectra do not permit the 
major metabolite concerned to be characterized 
further, however, since both isomeric benzo(a)pyrene 
diol-epoxides give similar fluorescence spectra after 
reaction with DNA. It has been suggested that free 
radicals [ 131, radical cations [ 141 and hydroxy- 
methyl derivatives [ 151, formed from benzo(a)pyrene, 
may react with DNA in vivo; these types of interme- 
diates could conceivably be involved in the formation 
of the unidentified fluorescent component (fig.2(a), 
III) that is present in benzo(a)pyrene-treated mouse 
skin DNA but more information would be neces- 
sary to show this. The results which we have obtained 
with benzo(a)pyrene and those reported for 7-methyl- 
benz(a)anthracene [S] demonstrate the high sensitivi- 
ty of this photoncounting spectrophotofluorometer. 
One important advantage of this instrument is that it 
allows polycyclic hydrocarbon derivatives that be- 
come bound to nucleic acids in vivo to be examined 
without the need to synthesise radioactively-labelled 
compounds. Since the instrument also provides the 
only available means of characterizing these hydro- 
carbon residues, it is intended to apply the spectra- 
photofluorometer to other carcinogenic aromatic 
hydrocarbons whose metabolic activation is being 
investigated. 
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